Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Minocycline hydrochloride |
Is a |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Minocycline measurement |
Component |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing minocycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Accidental minocycline poisoning |
Causative agent (attribute) |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Intentional minocycline poisoning |
Causative agent (attribute) |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
intoxication par la minocycline d'intention indéterminée |
Causative agent (attribute) |
False |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Minocycline adverse reaction |
Causative agent (attribute) |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Allergy to minocycline |
Causative agent (attribute) |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Minocycline overdose |
Causative agent (attribute) |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Accidental minocycline overdose |
Causative agent (attribute) |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Intentional minocycline overdose |
Causative agent (attribute) |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
surdose de minocycline d'intention indéterminée |
Causative agent (attribute) |
False |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Minocycline 100mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Product containing precisely minocycline 50 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Product containing precisely minocycline 100 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Product containing precisely minocycline 50 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Product containing precisely minocycline 100 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Minocycline 10mg dental gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Product containing precisely minocycline 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Poisoning by minocycline |
Causative agent (attribute) |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Minocycline hydrochloride 100mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Minocycline hydrochloride 1mg oral microspheres |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Accidental minocycline poisoning |
Causative agent (attribute) |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Intentional minocycline poisoning |
Causative agent (attribute) |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Minocycline adverse reaction (disorder) |
Causative agent (attribute) |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Minocycline sensitivity |
Causative agent (attribute) |
False |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Minocycline 45mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Minocycline 90mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Minocycline 135mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Minocycline-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing minocycline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing minocycline in oropharyngeal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Allergy to minocycline |
Causative agent (attribute) |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline 50 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline 50 milligram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline 100 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline 100 milligram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline 50 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline 50 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline 100 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline 100 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Minocycline hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
|
Minocycline 135mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Minocycline 90mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Minocycline 45mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Minocycline 100mg gastro-resistant and prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline (substance) |
Inferred relationship |
Some |
|
Product containing precisely minocycline 50 milligram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline 100 milligram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline 50 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline 100 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing only minocycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing only minocycline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Minocycline only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing only minocycline in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Minocycline (as minocycline hydrochloride) 100 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline (as minocycline hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline (as minocycline hydrochloride) 50 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Minocycline (as minocycline hydrochloride) 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing minocycline in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline (as minocycline hydrochloride) 15 milligram/1 gram conventional release cutaneous foam (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Minocycline only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing minocycline in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Minocycline (as minocycline hydrochloride) 75 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline (as minocycline hydrochloride) 20 milligram/1 gram conventional release periodontal gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Minocycline-containing product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Minocycline only product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Hypersensitivity to minocycline (finding) |
Causative agent (attribute) |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline (as minocycline hydrochloride) 100 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Minocycline (substance) |
Inferred relationship |
Some |
1 |